Humedix Co., Ltd. (KOSDAQ:200670)
26,150
-100 (-0.38%)
Aug 31, 2026, 3:30 PM KST
Humedix Market Cap
Humedix has a market cap or net worth of 269.87 billion as of August 31, 2026. Its market cap has decreased by -51.84% in one year.
Market Cap
269.87B
Enterprise Value
n/a
Revenue
110.99B
Ranking
n/a
PE Ratio
27.13
Stock Price
26,150.00
ChartMarket Cap Chart
Since December 26, 2014, Humedix's market cap has increased from 223.01B to 269.87B, an increase of 21.01%. That is a compound annual growth rate of 1.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 269.87B | -35.19% |
| Dec 30, 2025 | 416.42B | -4.39% |
| Dec 30, 2024 | 435.54B | 24.67% |
| Dec 28, 2023 | 349.36B | 38.28% |
| Dec 29, 2022 | 252.65B | 12.18% |
| Dec 30, 2021 | 225.21B | -0.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dong-A ST | 368.68B |
| EuBiologics | 349.51B |
| JW Holdings | 286.45B |
| Huons | 258.67B |
| Korea United Pharm | 255.22B |
| Suheung | 255.02B |
| Samjin Pharmaceuticals | 225.91B |
| Yungjin Pharm. | 211.24B |